across the hepatic circulation, the figure obtained is net glucose production, i.e., glucose production minus glucose uptake, and may assume a negative value under some conditions. When glucose production is measured by isotope dilution, as in the present study, the figure obtained represents new (C12) glucose release to the circulating blood, presumably almost entirely from the liver; theoretically this might become zero but cannot become negative.
In some of the experiments reported here, the immediate effect of rather small amounts of infused insulin on the rate of glucose-C2 production has been measured in trained, unanesthetized, normal dogs. In these experiments glucose was also infused to prevent, or limit, hypoglycemia.
In other experiments glucose was infused alone, to create mild hyperglycemia and so to increase the rate of endogenous insulin secretion. Trace amounts of glucose-C4 were employed to measure glucose production and uptake.
MATERIALS AND METHODS
All experiments were carried out on trained, normal mongrel dogs (I 5-24 kg), without general anesthesia, at I 7-20 hr after the last feeding. Many of the experiments were done in such a way that liver biopsy samples, required for another purpose, could be taken; in these instances the dogs were in standing position in a harness. Otherwise the dogs were in reclining position. In all instances the respiratory mask (41) to carry away exhaled Cl402 was in place over the head of the dog. A standard diet previously described (g), containing was of such glucose-C4 content that an amount of Cl4 equal to that contained in the priming dose was delivered in about I 25 min. Glucose or insulin and glucose infusions were started about 3 hr after the initial glucose-Cl4 injection, subsequent to a a-hr period of sampling for determining control body glucose pool size and turnover rate. Glucose in bulk amount, whether given along with insulin to limit hypoglycemia or by itself, was infused at a measured rate in [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] % solution in water into a saphenous vein. Bulk glucose infusions always contained enough glucose-Cl4 to bring the specific activity of the administered glucose near to that already prevailing in the circulating plasma glucose. The insulin was trypsin-treated (glucagon-low) crystalline zinc insulin freshly dissolved in saline brought to pH 3 with HCl. It was infused into a cephalic vein.
Blood The plasma glucose concentration during the periods of insulin infusion was prevented from falling to low levels by infusion of varying amounts of glucose as shown in Fig. I . The highest amount of glucose infused was about four times the amount which the animal produced in the control period.
The effect of insulin to decrease glucose production was accompanied in all instances (except in ex/~ B-45) by an increase in over-all glucose uptake.
For representative data see the accompanying
PaPer (6) 3 where uptakes for all experiments of Fig. I and 2 except exp. B-40, AL-39, AL-38HC, and AL-3gHC are given.
Maintenance of the animals on a high-carbohydrate diet was not necessary to elicit the effect of insulin infusion on glucose-C2 proof glucose. Abbreviations as in Fig. 11 tions and specific activities. When bulk glucose was infused, the rate of introduction of the Cl4 associated with the bulk glucose was added to the rate of trace glucose-C4 infusion in performing the calculations; the final glucose-C2 production rate so calculated was corrected by subtraction of the rate of infusion of the bulk glucose-C2 in order to obtain the rate of endogenous glucose-C2 production.
RESULTS
Insulin infusion with hypoglycemza limited by glucose infusion. The consistent finding in these experiments is that insulin infusion, accompanied by glucose infusion to minimize hypoglycemia, results in a significant depression of hepatic glucose-C2 production.
As shown in duction. The last two experiments shown in Fig. I were done using dogs which had been maintained prior to the experiment for 5 and IO days, respectively, on the high-carbohydrate diet. These are not sufficient to allow judgment as to whether glucose-C2 production is more sensitive to insulin infusion in dogs kept on a highcarbohydrate diet. Glucose infusion. In Fig. 2 are shown the results of nine experiments in which glucose was infused at increasing rates; the last four of these were done using animals maintained on the high-carbohydrate diet prior to the experiment for I o, 7, 22, and 8 days, respectively. When glucose infusion was begun at a rate corresponding to one-half to one and one-half times the pretreatment glucose production rate, hepatic glucose-C2 production was depressed by 40 % or more after about 30 min in all of the nine experiments; in five of the experiments (AL-39, B-43, AL-38, B-3', and B-33) this extent of depression of glucose-Cl2 production was visible in the first half-hour of glucose infusion, when plasma glucose concentration was elevated by only 4-44 mg/ IOO ml (mean I 7 mg/roo ml) above the pretreatment level. In seven of the experiments (AL-39, B-43, B-47, B-48, AL-38, AL-39, and B-33) hepatic glucose-C2 production was depressed by 80 % or more during a period of the glucose infusion.
This occurred 75-135 min after the beginning of glucose infusion, at a time when plasma glucose concentration was elevated 13-65 mg/~oo ml (mean 45 mg/~oo ml) above the pretreat-STEELE ET AL. ment level, and when glucose infusion was proceeding at 1.6-5.0 times (mean 3.4 times) the pretreatment rate of endogenous glucose production. On cessation of glucose infusion, plasma glucose concentrations quickly fell to around the preinsulin level (4 exp.) or somewhat below (3 exp.) and hepatic glucose-C12 production increased (except for exp. B-32) above the last value observed during glucose infusion. The depressing effect of the glucose infusion on endogenous glucose-Cl2 production was seen in all animals, whether kept on the regular or the high-carbohydrate diet prior to the experiment.
Efect of hzgh-carbohydrate duet on rate of glucose turnover in the postabsorptive state. In the I 2 experiments performed on animals kept on the mixed diet, glucose production and uptake during the control period ranged from 130 to 247 mg/kg per hr with a mean value of I 84 h IO (SE) mg/kg per hr, as seen in Fig. I and 2. This is a somewhat higher value than has been observed in a large series of animals lying at rest. Most of the animals of the current series were standing in a harness during the control period.
In the six experiments performed on the animals on the high-carbohydrate diet, pretreatment glucose production and uptake ranged from 187 to 306 mg/kg per hr with a mean value of 247 =t Ig mg/ kg per hr, as seen in Fig. I and 2 . The increased glucose turnover of the animals on the high-carbohydrate diet was not associated with a corresponding increase in resting plasma glucose concentration. The animals fed the mixed diet had a mean plasma glucose concentration of IOI mg/ I oo ml; the animals fed the high-carbohydrate diet, 104 mg/Ioo ml.
DISCUSSION
The use of glucose-Cl4 to measure the effect of insulin on new (C12) glucose production has given rise to conflicting observations.
In the human subject (24, 3 I, 33), in the dog (16, 30) , and occasionally in the rabbit (4, 5), insulin has been said to lower glucose-Cl2 production. Other experiments in the dog (22, 34, 42) and rat (2) have led to statements that insulin does not lower glucase-Cl2 production.
In our own earlier studies in dogs the first effect of insulin on glucose production which was reported (43) Thereafter glucose production became nearly normal as the blood glucose concentration continued to fall, and after about 20 min rose far above normal as the blood glucose concentration began to rise again. Later (8, IO, I 5, I 7) it was observed that on prolonged continuous infusion of insulin (.07-. I 7 U/kg per hr, iv) the increased glucose-Cl2 production of the dog in response to the insulin-induced hypoglycemia was restrained as long as the insulin infusion was continued, this restraint being released when the insulin infusion was terminated. Subsequently (I 8) it was found that insulin infusion slowed to normal the accelerated rate of glucose-C? production brought about in the dog by acute phlorizin poisoning. A similar restraint by insulin on the increased glucose production brought about by glucagon was also reported at that time, but this effect has since proven to be impossible to reproduce consistently.
Finally it was reported (I I, I 2) that, in dogs maintained on a high-carbohydrate diet, insulin infusion accompanied by glucose infusion to prevent hypoglycemia caused a diminution of the rate of glucase-Cl2 production; preliminary observations were also reported indicating that a similar effect could be obtained in dogs maintained on a normal mixed diet. The experiments involving insulin infusion which are reported in this communication establish firmly that an increase in the amount of insulin which is introduced into the circulating blood of the dog in the postabsorptive state to above the amount normally being delivered from endogenous sources causes a decrease in the resting rate of g1ucose-C12 production by the liver, provided that glucose is also infused to prevent the development of hypoglycemia.
The effect is seen whether the dog has been maintained on a high-carbohydrate diet or on a standard diet prior to the experiment.
Not enough experiments were done using the high-carbohydrate diet to add to or detract from the observations of Leonards et al. (26), who reported a greater reduction in net glucose output (rather than glucose-Cl2 production) during insulin infusion in dogs kept on a high-carbohydrate diet. It is of interest that the inhibition by insulin of net glucose production in the dog, as measured by transhepatic catheterization, is also observable only when hypoglycemia is controlled. When hypoglycemia was allowed to develop fully after insulin, a number of investigators (19, 34, 42) found no decrease in net glucose production.
Leonards et al., using unanesthetized dogs kept on a high-carbohydrate diet (26), and Madison and colleagues (2 7)) using anesthetized dogs with previously established portacaval shunts, observed decreases in net glucose production only when hypoglycemia was limited to about 20 mg/Ioo ml or less below the preinsulin level. Madison and associates, but not Leonards and co -workers, were able to accomplish this by giving insulin intravenously at a low rate without an accompanying glucose infusion. Only on rare occasions in our own experiments has glucose-Cl2 production in the unanesthetized dog been seen to be significantly inhibited during insulin infusion at a low rate in the absence of glucose infusion.
In the human the long-standing evidence (3, 7) regarding insulin inhibition of net glucose production, as measured by transhepatic catheterization, is less secure because portal vein glucose concentrations were not observed and any possible action of insulin to increase glucose uptake by the tissues drained by the portal vein would have contributed to the arteriovenous glucose differences observed. Net splanchnic glucose "production," so measured, was seen to be inhibited by intravenous insulin injection even though hypoglycemia was allowed full development. Several investigators using glucose-Cl4 (24, 31, 33) have reported that g1ucose-C12 production in the normal human subject was inhibited after the subcutaneous injection of insulin, and remained inhibited for a long period even though the blood sugar concentration was allowed to fall as much as 40-50 mg/~oo ml below the preinsulin level. This seeming difference in the response of the human, if it is real, requires elucidation.
Intravenous glucose administration in a single large dose was claimed (30, 32) to stop glucose-Cl2 production in the dog immediately, whereas other investigators (40) failed to obtain this effect. The positive findings were made doubtful by the observation (39) that injection of a large glucose-C l2 load in eviscerated dogs, with body glucose tagged with Cl4 and with plasma glucose concentration maintained by a continuous infusion of glucose (instead of by the liver), gives a similar false impression of cessation of glucose-Cl2 input. However, in sheep, continuous infusion of suitably tagged glucose was shown to inhibit endogenous glucose-Cl2 production very markedly ( > I .
In our own earlier studies (8, IO, I 2) two of three animals were observed to respond to a suitably tagged glucose load by a decrease in glucose-C12 production; however, in the first of these studies (8, IO) little significance was attributed to this effect. The experiments reported here, also utilizing CF4-tagged glucose loads to avoid the artifact produced by slow mixing of a glucose-Cl2 load with part of the tagged body glucose pool, establish firmly that prolonged infusion of glucose alone in gradually increasing amounts causes a decrease in the rate of glucose-U2 production by the liver.
Net glucose production in the normal dog, as measured by transhepatic catheterization, was shown to be decreased by oral glucose administration in 1937 by Cherry and Crandall (I 3). A number of investigators (14, 25, 36) have since demonstrated that intravenous glucose infusion decreases net hepatic glucose production.
It is presumed that infused glucose decreases glucase-Cl2 production by causing an increase in the rate of endogenous insulin secretion, and that this sequence of events reflects one of the parts played by insulin in ordinary circumstances, i.e., after ingestion of a carbohydrate-containing meal. Landau and coworkers (25), in discussing their finding that a highcarbohydrate diet accentuates the inhibition by infused glucose of net hepatic glucose output, mention two possible reasons. One is a greater increase in the secretion of insulin in response to hyperglycemia and the other is an inherently greater increase in glucose uptake by liver at elevated glucose concentrations due to alterations brought about by the diet in the levels of hepatic enzymes concerned with glucose utilization. In the course of the present work, also, the impression has been gained that plasma glucose concentrations in dogs fed the highcarbohydrate diet do not rise as high at a given rate of glucose infusion as in dogs fed the standard diet. A c greater increase in the secretion of insulin in response to hyperglycemia is the acceptable explanation for this difference in view of observations of glucose uptake by liver presented elsewhere (6). Thus in the early periods of glucose infusion in the present experiments glycogen-C l2 loss was strongly inhibited with little stimulation of glucose-Cl4 incorporation into glycogen. This early relationship was evident also in dogs infused with insulin at plasma glucose concentration which were maintained at the normal level. Since increased glucose uptake by liver at this time should have resulted in a concomitant increase in glucose-Cl4 incorporation into glycogen it is suggested that, in these early periods increased glucose uptake by the liver did not play an important part in decreasing net hepatic glucose output or glucose-Cl2 release in either the high-carbohydrate or normally fed animals. In later periods of glucose infusion, when greatly increased glucose uptake by the liver became apparent (6), an inherently greater capacity of the livers of the dogs fed the high-carbohydrate diet to take up more glucose under the influence of insulin may also have played a part in limiting the rise in plasma glucose concentration and in decreasing glucose-Cl2 production.
Not enough animals on the high-carbohydrate diet were studied to make a valid comparison with normal dogs in this respect.
In any event the present experiments demonstrate that maintenance of the animal on a high-carbohydrate diet prior to the experiment is not a necessary condition for the demonstration of decreased glucose-C12 release by liver in response either to insulin infusion at normal plasma glucose levels or to glucose infusion with elevated plasma glucose levels.
The simplest explanation for the depressing effect of insulin on hepatic glucose-C12 production is that insulin acts directly on the hepatic cells to produce the effect. Here, inhibition by insulin of glucose-Cl2 production could be erroneously interpreted in the sense that it actually results from a stimulatory effect of insulin exerted in another direction.
However, another possible explanation for a part of the effect of insulin on the liver, i.e., inhibition of glycogenolysis, does involve a decrease in the rate of hexose-Cl2 production inside the hepatic cell. In this case the decreased glucose-Cl2 release from the liver would be a straightforward indication of a mechanism involved in insulin action. These possibilities and the relationship of increased hepatic glucose uptake to glucose-U2 release are discussed fully elsewhere (6).
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